Vertex Pharmaceuticals Cash Flow Statement (2009-2025) | VRTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	653.10M	67.00M	851.90M	770.10M	762.10M	810.50M	930.50M	818.90M	699.80M	915.70M	1,035.30M	968.80M	1,099.60M	-3593.60M	1,045.40M	913.00M	646.30M	1,032.90M	1,082.90M	1,191.10M
Share-based Compensation (Quarter)	115.20M	104.60M	103.00M	118.60M	130.30M	113.90M	135.60M	111.50M	122.40M	119.30M	130.90M	208.60M	191.90M	154.20M	184.60M	167.80M	166.10M	167.30M	194.90M	157.60M
Deferred Taxes (Quarter)	57.00M	-237.90M	68.20M	-41.90M	-12.30M	-229.40M	-182.30M	148.10M	-113.40M	-176.60M	-115.50M	-131.00M	-158.30M	-118.80M	-123.30M	51.60M	-191.60M	-113.80M	-235.90M	30.50M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	102.10M	1.60M	1.20M	94.80M	117.50M	-49.20M	-2.60M	-792.30M	10.60M	-0.60M	1.20M	1,644.40M	36.40M	0.50M	0.30M	381.90M	184.40M	-181.80M	1,174.70M	-1290.70M
Asset Writedowns and Impairment (Quarter)																	379.00M
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)
Cash from Operations (Quarter)	921.00M	-199.70M	927.20M	995.00M	956.20M	1,139.80M	955.50M	1,078.40M	899.90M	1,134.40M	1,268.40M	234.60M	1,306.60M	-3753.60M	1,369.80M	584.60M	818.90M	1,073.10M	1,241.40M	498.00M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Depreciation & Amortization (CF) (Quarter)	28.80M	31.30M	31.70M	33.80M	35.90M	37.30M	36.70M	38.40M	38.80M	41.40M	42.10M	59.00M	53.50M	54.00M	53.20M	46.50M	48.40M	51.70M	54.00M	55.70M
Change in Working Capital
Change in Receivables (Quarter)	98.40M	-52.50M	185.30M	43.50M	165.20M	84.10M	119.50M	-10.20M	90.50M	2.90M	6.10M	-15.40M	251.60M	-135.10M	51.80M	-69.00M	169.60M	18.40M	59.90M	99.40M
Change in Inventory (Quarter)	22.80M	24.70M	18.30M	27.00M	-2.00M	33.30M	26.80M	78.30M	82.60M	72.80M	97.50M	70.00M	80.10M	107.20M	182.50M	147.50M	167.10M	148.60M	131.10M	77.40M
Change in Account Payables (Quarter)	-10.60M	-13.70M	2.30M	53.90M	-14.50M	45.30M	-69.90M	159.90M	35.70M	35.60M	9.20M	-31.80M	0.10M	-25.10M	66.10M	8.40M	26.20M	7.60M	-35.30M	38.30M
Change in Accured Expenses (Quarter)	153.00M	-45.50M	-174.80M	84.10M	15.70M	531.40M	433.20M	-437.80M	89.40M	328.00M	-264.00M	55.50M	167.60M	-256.60M	622.00M	-320.10M	22.00M	-63.20M	83.90M	105.80M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	13.30M	78.90M	15.50M	-15.90M	-67.60M	-17.70M	127.20M	284.50M	-46.20M	19.60M	121.00M	451.30M	-99.20M	155.90M	-21.00M	164.60M	28.10M	76.40M	40.90M	250.60M
Investing Activities
Capital Expenditures (Quarter)	70.90M	49.90M	52.40M	61.80M	63.60M	53.30M	54.20M	33.60M	42.10M	59.60M	40.60M	58.10M	68.40M	69.00M	67.70M	92.60M	40.70M	145.70M	101.80M	149.40M
Change in Intangibles (Quarter)												58.00M	-180.00M	-7.70M		375.40M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)	118.10M	103.20M	230.80M	47.20M	129.70M	-129.70M		920.00M	50.00M	239.80M	-194.70M	744.00M	710.50M	1,182.60M	1,112.30M	1,460.20M	1,637.60M	1,838.70M	1,329.30M	-4789.60M
Cash from Investing Activities (Quarter)	-74.30M	-79.70M	-52.90M	-134.00M	-51.00M	-61.50M	-384.20M	175.60M	-1833.60M	-303.90M	-117.70M	-886.50M	-2136.40M	-463.70M	-348.00M	-821.90M	-55.80M	-484.50M	-117.00M	-288.10M
Financing Activities
Other financing activities (Quarter)	1.30M	1.60M	1.40M	1.40M	1.30M	0.40M	0.70M	1.10M	1.10M	1.10M	1.10M	-1.50M	3.50M	0.90M	0.90M	0.90M	0.80M	0.70M	1.10M	1.10M
Cash from Financing Activities (Quarter)	-518.70M	33.60M	-656.70M	-336.20M	-95.40M	47.70M	-60.20M	40.20M	-294.70M	17.30M	-165.00M	-119.80M	-357.50M	-358.60M	-387.50M	-391.30M	-680.40M	-349.20M	-1154.50M	-77.20M
Additional items
Exchange Rate Effect (Quarter)	-4.00M	4.00M	-8.50M	-4.90M	-5.90M	-25.90M	-38.20M	40.80M	12.00M	10.00M	-22.50M	27.40M	-15.60M	-2.50M	22.80M	-47.30M	30.50M	57.20M	-4.10M	7.30M
Change in Cash (Quarter)	324.00M	-241.80M	209.10M	519.90M	803.90M	1,100.10M	472.90M	1,335.00M	-1216.40M	857.80M	963.20M	-744.30M	-1202.90M	-4578.40M	657.10M	-675.90M	113.20M	296.60M	-34.20M	140.00M
Free Cash Flow (Quarter)	850.10M	-249.60M	874.80M	933.20M	892.60M	1,086.50M	901.30M	1,044.80M	857.80M	1,074.80M	1,227.80M	176.50M	1,238.20M	-3822.60M	1,302.10M	492.00M	778.20M	927.40M	1,139.60M	348.60M
Net Cash Flow (Quarter)	328.00M	-245.80M	217.60M	524.80M	809.80M	1,126.00M	511.10M	1,294.20M	-1228.40M	847.80M	985.70M	-771.70M	-1187.30M	-4575.90M	634.30M	-628.60M	82.70M	239.40M	-30.10M	132.70M

Research Tools

Vertex Pharmaceuticals Cash Flow Statement (2009-2025) | VRTX

Create an account

Sign In

Reset Password